Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Mar 21, 2009; 15(11): 1331-1338
Published online Mar 21, 2009. doi: 10.3748/wjg.15.1331
Published online Mar 21, 2009. doi: 10.3748/wjg.15.1331
Normal mucosa (Marsh 0) n = 6 | LE (Marsh I) n = 9 | Atrophy (Marsh III) n = 6 | Pvalue | |
Flatulence | 36.6 ± 12.0 (0-60) | 28.8 ± 8.2 (0-60) | 36.6 ± 14.7 (0-80) | 0.839 |
Distension | 6.67 ± 4.2 (0-20) | 28.8 ± 6.7 (0-60) | 50.0 ± 16.9 (0-100) | 0.035 |
Abdominal pain | 0.0 ± 0.0 (0-20) | 31.1 ± 10.0 (0-80) | 26.6 ± 9.8 (0-60) | 0.06 |
Diarrhea | 8.33 ± 8.3 (0-50) | 17.7 ± 9.1 (0-80) | 30.0 ± 12.3 (0-80) | 0.384 |
Asthenia | 10.0 ± 6.8 (0-40) | 11.1 ± 7.5 (0-60) | 50.0 ± 16.9 (0-100) | 0.031 |
- Citation: Mariné M, Fernández-Bañares F, Alsina M, Farré C, Cortijo M, Santaolalla R, Salas A, Tomàs M, Abugattas E, Loras C, Ordás I, Viver JM, Esteve M. Impact of mass screening for gluten-sensitive enteropathy in working population. World J Gastroenterol 2009; 15(11): 1331-1338
- URL: https://www.wjgnet.com/1007-9327/full/v15/i11/1331.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.1331